Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research

24.05.2017

The research groups lead by Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader and Dr. Mike Karl at the DFG-Research Center for Regenerative Therapies Dresden (CRTD) – Cluster of Excellence at TU Dresden, have received funding in the BMBF program “Validation of the technological and societal innovation potential of scientific research – VIP+” with their CLEANSIGHT research team. The research project will focus on validating a retinal cell–based screening platform for fast and efficient identification of small molecules for the treatment of retinal degenerative diseases.

With more than 150 million affected people, retinal degenerative diseases are one of the most frequent causes of visual impairment worldwide. Examples include genetically inherited Retinitis Pigmentosa (RP), and age-related macular degeneration (AMD). The prevalence of AMD is expected to reach epidemic proportions due to an increasingly aging population. There are currently no effective therapies to prevent or cure these diseases.


Retinal pigment epithelial cell culture & Cleansight team (left to right): Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader, Dr. Mike Karl, Dr. Seba Almedawar, Dr. Sven Schreiter & Dr. Dominic Eberle

© CRTD, Dominic Eberle

Retinal diseases are associated with build-up of waste products. Vision loss may occur, for example, when the retinal pigment epithelial cells (RPE), which underlie the neural retina, are impaired in taking up and recycling natural waste products of the retina.

This process, known as phagocytosis, is essential for visual function and survival of our light sensitive retinal neurons, called photoreceptors. Abnormal RPE cell function can lead to retinal degeneration, visual impairment and even loss of sight. Therapeutic compounds modulating RPE functions might prevent vision loss.

”The aim of CLEANSIGHT is to validate a RPE-based screening platform, which we have developed since 2013, to search for classes of compounds that are suitable candidates for the development of novel therapeutics, and bring it to industry standards. RPE cells used in this platform are derived from human stem cells by a patented and very efficient protocol, which made the platform development possible”, explains the research team consisting of Dr. Seba Almedawar (project leader), Dr. Sven Schreiter and Dr. Dominic Eberle, supported by Prof. Elly Tanaka, Prof. Marius Ader and Dr. Mike Karl. A procedure patented by Prof. Tanaka enables the production of large quantities of human RPE cells at uniformly high quality in the laboratory. This constitutes a major advance for the development of a screening platform for new therapeutic substances.

The awarded research grant is part of the new Hightech-Strategy „Innovationen für Deutschland“ of the German Federal Government. The rapid transfer of innovative ideas for products and services aims to strengthen Germany’s leading position as the largest national economy and exporter in Europe.

The Grant Office, CMCB (a service unit that supports CRTD, BIOTEC and B CUBE in the acquisition of third-party funds) and the Technology Transfer Office have both closely coordinated the CLEANSIGHT grant application and continue to offer their support to the project team.

Further information on CLEANSIGHT (Dresdner Transferbrief, Issue 2.16)
http://www.qucosa.de/fileadmin/data/qucosa/documents/20367/transferbrief_ausgabe... (pages 10-11)

Press Contact
Franziska Clauß
Press Officer
Phone: +49 351 458 82065, e-Mail: franziska.clauss@crt-dresden.de

Founded in 2006, the DFG Research Center for Regenerative Therapies Dresden (CRTD), Cluster of Excellence at the TU Dresden has passed the second phase of the Excellence Initiative which aims at promoting top-level research and improving the quality of German universities and research institutions. The goal of the CRTD is to explore the body's self-healing potential and to develop completely new, regenerative therapies for hitherto incurable diseases. The key areas of research include haematology and immunology, diabetes, neurodegenerative diseases and bone regeneration. At the moment, eight professors and ten group leaders are working at the CRTD – integrated into an interdisciplinary network of 87 members at seven different institutions within Dresden. In addition, 21 partners from industry are supporting the network. The synergies in the network allow for a fast translation of results from basic research to clinical applications.

www.crt-dresden.de

Franziska Clauß | idw - Informationsdienst Wissenschaft

More articles from Awards Funding:

nachricht Success at leading conference on silicon materials science and technology in Japan
13.12.2018 | IHP - Leibniz-Institut für innovative Mikroelektronik

nachricht Ultrasound Connects
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Pressure tuned magnetism paves the way for novel electronic devices

18.12.2018 | Materials Sciences

New type of low-energy nanolaser that shines in all directions

18.12.2018 | Physics and Astronomy

NASA research reveals Saturn is losing its rings at 'worst-case-scenario' rate

18.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>